Some agencies have been reporting that Natco Pharma’s fund raising plan might be expedited and take place in the next one or two months. Finance director and chief financial officer Bhaskar Narayana told CNBC-TV18 that the Rs 100 crore qualified institutional placement (QIP) would result in 7-8% dilution.
first published: Nov 4, 2011 03:50 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
Pine Labs’ Rs 3,900 Cr IPO| CEO Amrish Rau On Why The Issue Size Was Cut & The Post-IPO Gameplan
Can Nifty Claw Back Above 25,600 Or Will Sensex Expiry Cap The Upside?| Opening Bell Live
Gold ETFs vs Silver ETFs | Which One Is Your Wealth Buddy?
